These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 8830636)
1. [Resistance of herpes simplex virus to acyclovir: laboratory and clinical aspects]. Briazzhikova TS; Iurlova TI; Chizhov NP Antibiot Khimioter; 1995; 40(11-12):29-33. PubMed ID: 8830636 [TBL] [Abstract][Full Text] [Related]
2. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience. Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993 [TBL] [Abstract][Full Text] [Related]
3. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir]. Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981 [TBL] [Abstract][Full Text] [Related]
4. Frequency of acyclovir-resistant herpes simplex virus in clinical specimens and laboratory isolates. Shin YK; Cai GY; Weinberg A; Leary JJ; Levin MJ J Clin Microbiol; 2001 Mar; 39(3):913-7. PubMed ID: 11230403 [TBL] [Abstract][Full Text] [Related]
5. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus]. Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669 [TBL] [Abstract][Full Text] [Related]
6. [Contribution of the laboratory in case of resistance to acyclovir of herpes simplex and varicella zoster virus]. Morfin F; Frobert E; Thouvenot D Ann Biol Clin (Paris); 2003; 61(1):33-40. PubMed ID: 12604384 [TBL] [Abstract][Full Text] [Related]
7. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed. Schmit I; Boivin G J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866 [TBL] [Abstract][Full Text] [Related]
8. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088 [TBL] [Abstract][Full Text] [Related]
9. Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum. Levin MJ; Weinberg A; Leary JJ; Sarisky RT Pediatr Infect Dis J; 2001 Nov; 20(11):1094-7. PubMed ID: 11734722 [TBL] [Abstract][Full Text] [Related]
10. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples. Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus. Safrin S; Phan L Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152 [TBL] [Abstract][Full Text] [Related]
12. [In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?]. Losada I; Cañizares A; Hellín T; Martí-Belda P; Guerrero A Enferm Infecc Microbiol Clin; 2002 Jan; 20(1):25-7. PubMed ID: 11820977 [TBL] [Abstract][Full Text] [Related]
13. Treatment of acyclovir-resistant herpes simplex and varicella zoster virus infections. Safrin S Adv Exp Med Biol; 1996; 394():59-66. PubMed ID: 8815710 [No Abstract] [Full Text] [Related]
14. Rapid method for determining the susceptibility of herpes simplex virus to acyclovir. Howell CL; Miller MJ Diagn Microbiol Infect Dis; 1984 Apr; 2(2):77-84. PubMed ID: 6325082 [TBL] [Abstract][Full Text] [Related]
15. Survey of acyclovir-resistant herpes simplex virus in the Netherlands: prevalence and characterization. Stránská R; Schuurman R; Nienhuis E; Goedegebuure IW; Polman M; Weel JF; Wertheim-Van Dillen PM; Berkhout RJ; van Loon AM J Clin Virol; 2005 Jan; 32(1):7-18. PubMed ID: 15572000 [TBL] [Abstract][Full Text] [Related]
16. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection. Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398 [TBL] [Abstract][Full Text] [Related]
17. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients]. Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058 [TBL] [Abstract][Full Text] [Related]
18. Resistance of herpes simplex virus to antiviral agents. Is it clinically important? Crumpacker C Drugs; 1983 Nov; 26(5):373-7. PubMed ID: 6315331 [No Abstract] [Full Text] [Related]
19. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome. Chatis PA; Miller CH; Schrager LE; Crumpacker CS N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137 [No Abstract] [Full Text] [Related]
20. Clinical resistance to acyclovir of herpes simplex virus infections in immunocompromised patients. Christophers J; Sutton RN; Noble RV; Anderson H J Antimicrob Chemother; 1986 Oct; 18 Suppl B():121-5. PubMed ID: 3025152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]